AIM ImmunoTech Inc. (AIM)
NYSEAMERICAN: AIM · Real-Time Price · USD
0.140
-0.003 (-1.96%)
At close: Feb 21, 2025, 4:00 PM
0.135
-0.005 (-3.50%)
After-hours: Feb 21, 2025, 7:51 PM EST
AIM ImmunoTech Market Cap
AIM ImmunoTech has a market cap or net worth of $8.82 million as of February 21, 2025. Its market cap has decreased by -58.59% in one year.
Market Cap
8.82M
Enterprise Value
5.02M
1-Year Change
-58.59%
Ranking
Category
Stock Price
$0.14
Market Cap Chart
Since December 1, 1998, AIM ImmunoTech's market cap has decreased from $159.00M to $8.82M, a decrease of -94.45%. That is a compound annual growth rate of -10.43%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Feb 21, 2025 | 8.80M | -30.16% |
Dec 31, 2024 | 12.60M | -41.40% |
Dec 29, 2023 | 21.50M | 43.33% |
Dec 30, 2022 | 15.00M | -65.91% |
Dec 31, 2021 | 44.00M | -39.56% |
Dec 31, 2020 | 72.80M | 1,517.78% |
Dec 31, 2019 | 4.50M | -48.28% |
Dec 31, 2018 | 8.70M | -20.91% |
Dec 29, 2017 | 11.00M | -33.73% |
Dec 30, 2016 | 16.60M | -16.58% |
Dec 31, 2015 | 19.90M | -60.20% |
Dec 31, 2014 | 50.00M | 12.61% |
Dec 31, 2013 | 44.40M | 17.15% |
Dec 31, 2012 | 37.90M | 43.56% |
Dec 30, 2011 | 26.40M | -60.42% |
Dec 31, 2010 | 66.70M | -10.23% |
Dec 31, 2009 | 74.30M | 166.31% |
Dec 31, 2008 | 27.90M | -50.18% |
Dec 31, 2007 | 56.00M | -59.97% |
Dec 29, 2006 | 139.90M | 19.27% |
Dec 30, 2005 | 117.30M | 24.79% |
Dec 31, 2004 | 94.00M | 10.33% |
Dec 31, 2003 | 85.20M | 24.74% |
Dec 31, 2002 | 68.30M | -50.29% |
Dec 31, 2001 | 137.40M | -2.21% |
View and export this data all the way back to 1998.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Eli Lilly and Company | 784.71B |
UnitedHealth Group | 429.24B |
Novo Nordisk | 391.83B |
Johnson & Johnson | 390.76B |
AbbVie | 356.74B |
Abbott Laboratories | 234.01B |
AstraZeneca | 229.50B |
Merck & Co. | 226.40B |